Knoll Capital Management, LLC
MIAMI, FL · CIK 1325083 · 13F filing filed 2020-08-14
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
- Others nearbyMiami, FL
$173.2m
reported value
+62.7% vs Q1 2020
19positions
92.8%in top 10
1 new
2 added
1 reduced
0 sold out
vs Q1 2020
Holdings, Q2 2020
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| BIOHAVEN PHARMACTL HLDG CO L BHVN | $62.1m35.84% | Unchanged |
| CORBUS PHARMACEUTICALS HLDGS CRBP | $42.3m24.44% | Unchanged |
| APPLIED THERAPEUTICS INC APLT | $23.0m13.27% | Added +8.2k |
| ABEONA THERAPEUTICS INC COM | $8.2m4.71% | Unchanged |
| Orgenesis, Inc. COM | $8.0m4.62% | New |
| EIGER BIOPHARMACEUTICALS INC CLDN | $5.1m2.92% | Added +50.0k |
| ANAVEX LIFE SCIENCES CORP AVXL | $3.6m2.09% | Unchanged |
| EXICURE INC XCUR | $3.1m1.77% | Unchanged |
| ENTERA BIO LTD ENTX | $3.0m1.74% | Unchanged |
| ALDEYRA THERAPEUTICS INC ALDX | $2.4m1.37% | Unchanged |
| BLACKSTONE GROUP L P BX | $2.2m1.30% | Reduced -40.0k |
| CENTURYLINK INC CTL | $2.2m1.25% | Unchanged |
| SOLIGENIX INC COM | $1.6m0.91% | Unchanged |
| MOLECULAR TEMPLATES INC COM | $1.5m0.89% | Unchanged |
| DOW INC DOW | $1.2m0.71% | Unchanged |
| CATASYS INC COM PAR | $1.1m0.63% | Unchanged |
| BIOXCEL THERAPEUTICS INC COM | $1.1m0.62% | Unchanged |
| CORTEVA INC CTVA | $811.0k0.47% | Unchanged |
| DUPONT DE NEMOURS INC DWDP | $785.0k0.45% | Unchanged |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.
| Company | Stake |
|---|---|
| ELICIO THERAPEUTICS INC ELTX · 13G · filed 2026-07-08 | 5.3%≈ $4.7m |